Lines designed for safe use in humans make their debut.

Four ‘safe’ embryonic stem-cell lines, which have been made from scratch specifically for clinical use, make their debut this week. Singapore-based biotech company ESI will announce on 27 July the existence of these lines, plus four more in the pipeline, and have said they will make them available to researchers worldwide by the end of this year.

Read the story here.

and more about stem cells in America and Europe this week (you’ll need a sub) here.